Scott Dunseth Myers is Director of DYNAVAX TECHNOLOGIES CORP. Currently has a direct ownership of 31,204 shares of DVAX, which is worth approximately $348,236. The most recent transaction as insider was on Jun 11, 2025, when has been sold 5,758 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.2K
22.63% 3M change
22.63% 12M change
Total Value Held $348,236

Scott Dunseth Myers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Grant, award, or other acquisition
-
5,758 Added 15.58%
31,204 Common Stock
May 23 2024
BUY
Grant, award, or other acquisition
-
5,357 Added 17.39%
25,446 Common Stock
May 26 2023
BUY
Grant, award, or other acquisition
-
5,357 Added 21.05%
20,089 Common Stock

Also insider at

AMAG
AMAG PHARMACEUTICALS, INC.
SELB
SELECTA BIOSCIENCES INC Healthcare
HARP
Harpoon Therapeutics, Inc. Healthcare
VRDN
Viridian Therapeutics, Inc.\DE Healthcare
ZNTL
Zentalis Pharmaceuticals, Inc. Healthcare
SDM

Scott Dunseth Myers

Director
Emeryville, CA

Track Institutional and Insider Activities on DVAX

Follow DYNAVAX TECHNOLOGIES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVAX shares.

Notify only if

Insider Trading

Get notified when an Dynavax Technologies Corp insider buys or sells DVAX shares.

Notify only if

News

Receive news related to DYNAVAX TECHNOLOGIES CORP

Track Activities on DVAX